Dr Luca Peruzzotti-Jametti University positionClinical Research Associate DepartmentsDepartment of Clinical Neurosciences Home pagehttps://scholar.google.com/citatio... Research ThemesInterestsMy research focuses on the mechanisms driving chronic CNS damage in conditions of neuroinflammation, such as multiple sclerosis (MS). Currently I am studying how progression works in MS by focusing on the link between immune cell metabolism and chronic neuroinflammation. Research Focus
EquipmentBehavioural analysis Calcium imaging Cell culture Confocal microscopy Enzyme assays Fluorescence microscopy Immunohistochemistry Microscopy Seahorse Collaborators
Associated News ItemsKey publicationsPluchino S, Smith JA, Peruzzotti-Jametti L. (2020), “Promises and Limitations of Neural Stem Cell Therapies for Progressive Multiple Sclerosis.” Trends in Molecular Medicine Peruzzotti-Jametti L, Bernstock JD, Vicario N, Costa ASH, Kwok C, Leonardi T, Booty L, Bicci I, Balzarotti B, Volpe G, Mallucci G, Manferrari G, Iraci N, Braga A, Hallenbeck JM, Murphy MP, Edenhofer F, Frezza C and Pluchino S. (2018), “Macrophage-derived extracellular succinate licenses neural stem cells to ameliorate chronic neuroinflammation. ” Cell Stem Cell Peruzzotti-Jametti L, Pluchino S. (2018), “Targeting Mitochondrial Metabolism in Neuroinflammation: Towards a Therapy for Progressive Multiple Sclerosis.” Trends in Molecular Medicine Iraci N, Gaude E, Leonardi T, Costa ASH, Cossetti C, Peruzzotti-Jametti L, Bernstock JD, Saini HK, Gelati M, Vescovi AL, Bastos C, Faria N, Occhipinti LG, Enright AJ, Frezza C, Pluchino S (2017), “Extracellular vesicles are independent metabolic units with asparaginase activity. ” Nature Chemical Biology Spescha RD, Klohs J, Semerano A, Giacalone G, Derungs RS, Reiner MF, Rodriguez Gutierrez D, Mendez-Carmona N, Glanzmann M, Savarese G, Kränkel N, Akhmedov A, Keller S, Mocharla P, Kaufmann MR, Wenger RH, Vogel J, Kulic L, Nitsch RM, Beer JH, Peruzzotti-Jametti L, Sessa M, Luscher TF, Camici GG. (2015), “Post-Ischemic Silencing of p66Shc Reduces Ischaemia/Reperfusion Brain Injury and its Expression Correlates to Clinical Outcome in Stroke.” European Heart Journal Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators (..Comi G, Peruzzotti L, Cuccia C..). (2013), “Edoxaban versus warfarin in patients with atrial fibrillation. ” New England Journal of Medicine |